Screen wastewater effluents for genotoxic hazard — rapidly, reliably, and without knowing what’s in them
Industrial, municipal, and hospital effluents carry a complex load of genotoxic contaminants that chemical analysis alone cannot fully characterize. The EBPI UMU-ChromoTest™ uses a genetically engineered Salmonella typhimurium strain to detect aggregate DNA-damaging activity across the entire effluent mixture — in under eight hours, in a standard 96-well microplate format.
Effluent compliance chemistry doesn’t tell you if your discharge is damaging DNA
Wastewater effluents from industrial facilities, municipal treatment plants, and hospitals contain hundreds of organic compounds — pharmaceuticals, dyes, solvents, disinfection by-products, PAHs, and more. Many are genotoxic at trace concentrations. Chemical monitoring programs cover only a narrow fraction of regulated parameters and cannot assess the cumulative biological impact of the mixture.
Compliance chemistry identifies specific regulated analytes but cannot detect unknown genotoxins, assess synergistic effects of chemical mixtures, or confirm that treatment processes have actually reduced biological DNA-damaging activity — only that target compound concentrations have fallen.
A single bioassay that responds to the total genotoxic burden of an effluent sample. No prior knowledge of chemical content required. Used internationally to characterize effluent genotoxicity before and after treatment, confirm treatment efficacy, and screen for spills or anomalous loading events.
SOS response detection in Salmonella — optimized for complex environmental matrices
The UMU-ChromoTest™ exploits the SOS DNA repair system of Salmonella typhimurium TA1535/pSK1002, a strain specifically engineered for sensitivity to a broad range of environmental genotoxins relevant to wastewater matrices.
The engineered TA1535/pSK1002 strain carries the plasmid pSK1002, in which the umuC gene is fused in-frame to the lacZ reporter gene. Any genotoxic compound in the sample induces the umuC operon as part of the bacterial SOS DNA damage response, driving expression of β-galactosidase (β-gal). Bacteria are incubated in a sloped 96-well microplate for 2 hours at 37°C.
After the initial 2-hour incubation, fresh culture medium is added to achieve a 10-fold dilution. A further 2-hour incubation allows β-gal expression to accumulate. This post-treatment step reduces carry-over of cytotoxic compounds and improves signal-to-noise in complex effluent matrices.
β-galactosidase cleaves the chromogenic substrate, producing a colour change measured spectrophotometrically. Bacterial density (OD600) is simultaneously recorded to monitor cytotoxicity and distinguish true genotoxic effects from growth inhibition artifacts. Results are available within 8 hours of sample receipt.
Results are expressed as an induction ratio (IR) of β-gal activity relative to the negative control, normalized for bacterial density. An IR ≥ 1.5 indicates a genotoxic response under ISO 13829. Results can be expressed as relative enrichment factors (REF) when testing concentrated solid-phase extracts of complex effluents.
EBPI supplies rat liver S9 fraction for detection of indirect-acting pro-genotoxins requiring metabolic bioactivation before exerting DNA damage. The +S9 arm is particularly important for effluents containing PAHs, arylamines, nitroaromatics, and pharmaceutical metabolite precursors common in industrial and hospital wastewater streams.
Genotoxicity threshold: An induction ratio (IR) below 1.5 is considered non-genotoxic. IR ≥ 1.5 without growth inhibition is a positive genotoxic response. Samples showing combined cytotoxicity and genotoxicity (reduced OD600 plus elevated β-gal) are reported as cytotoxic-genotoxic, a distinction critical for effluent classification. The UMU-ChromoTest™ protocol complies with ISO 13829 (2000) and DIN 38415.
SOS-ChromoTest™ vs. UMU-ChromoTest™: complementary, not interchangeable
Both assays measure SOS-induced β-galactosidase activity and are standardized under ISO 13829, but they differ in organism, sensitivity profile, and regulatory heritage. For wastewater effluent characterization, the two assays are recommended in combination to maximize detection breadth.
| Feature | SOS-ChromoTest™ | UMU-ChromoTest™ |
|---|---|---|
| Test organism | Escherichia coli PQ37 | Salmonella typhimurium TA1535/pSK1002 |
| Reporter gene fusion | sfiA::lacZ (chromosomal) | umuC::lacZ (plasmid pSK1002) |
| Primary endpoint | SOS induction factor (IF) | umuC induction ratio (IR) |
| Turnaround time | ~6 hours | ~8 hours |
| Regulatory standard | ISO 13829 / OECD / US EPA | ISO 13829 / DIN 38415 |
| Strengths for wastewater | Broad-spectrum sensitivity; faster turnaround; established in drinking water research | High sensitivity to nitroaromatics, PAHs, fluoroquinolones; widely used in industrial & hospital effluent literature; post-treatment dilution step reduces matrix interference |
| Recommended use | Drinking water, source water, treatment process evaluation | Industrial effluents, WWTP discharge monitoring, hospital wastewater, pharmaceutical effluents |
Use both for complete coverage: The SOS-ChromoTest™ and UMU-ChromoTest™ are complementary assays. Studies have demonstrated that together they provide broader detection capacity and a more complete picture of the overall genotoxic potential of complex environmental samples than either assay alone. EBPI supplies both kits and can advise on combined testing strategies.
What the UMU-ChromoTest™ detects across effluent categories
The umuC assay has been used in peer-reviewed research to detect genotoxic activity across a wide range of wastewater sources. Key genotoxins identified in each category include:
Chemical plants, metallurgical operations, pulp and paper mills, and textile dyeing facilities. Key genotoxins include PAHs, chlorinated PAHs (Cl-PAHs), nitroaromatics, phenylbenzotriazoles (PBTAs), and polychlorinated biphenyls (PCBs). Historically among the highest genotoxic potencies observed in environmental water matrices.
Secondary and tertiary treated effluents. Genotoxic activity is linked to disinfection by-products, pharmaceutical residues, UV filters, personal care product degradation products, and chlorinated organics. The umuC assay is used to evaluate biological treatment and ozonation efficacy for genotoxicity removal before discharge to receiving waters.
Fluoroquinolone antibiotics (ciprofloxacin, norfloxacin) are the primary identified source of umuC genotoxicity in hospital wastewater, with umuC induction factors showing log-linear correlation with ciprofloxacin concentration. A 2-year monitoring study found genotoxic activity in 13% of over 800 native hospital wastewater samples tested by the umuC assay.
Active pharmaceutical ingredient (API) synthesis wastes and solvent-containing effluents. The +S9 metabolic activation arm is critical for detecting pro-genotoxic API precursors that require bioactivation. The umuC assay provides an early-screen biological endpoint for effluent streams where API chemical analysis may be restricted or prohibitively expensive.
Over three decades of validated use in wastewater genotoxicity research
The SOS/umuC assay has been applied in peer-reviewed literature to characterize, monitor, and reduce genotoxic risk in wastewater streams internationally. Key findings include:
Multi-matrix screening study: In a study evaluating genotoxicity and cytotoxicity across 51 samples (wastewaters, surface waters, and potable waters) using the SOS/umuC assay, 13 samples (25%) produced a genotoxic response — including samples from chemical industry effluents, a municipal WWTP, hospital wastewater, and receiving river and lake waters. This confirmed that downstream receiving waters can carry genotoxic burden derived from effluent discharges.
Hospital wastewater monitoring (2-year study): Over 800 native hospital wastewater samples were analyzed by the umuC assay across a 2-year period. Genotoxic activity was detected in 13% of samples, with the highest activity occurring in morning hours. Fluoroquinolone antibiotics — particularly ciprofloxacin (detected at 3–87 μg/L) — were identified as the primary genotoxic agent, showing a strong log-linear correlation with umuC induction factor (r² = 0.84, p < 0.0001). Antineoplastic drugs, originally considered the main effectors, were found to be of marginal significance in the umuC assay.
Advanced treatment evaluation (ozonation + activated carbon): At a pilot-scale WWTP, the umuC assay was used alongside chemical analysis of 16 organic compounds to assess ozonation and powdered activated carbon (PAC) filtration of secondary treated effluents. Ozone at 0.7 g/g DOC removed more than 90% of approximately half the target compounds chemically, but the umuC assay demonstrated that ozonation can increase short-term genotoxicity through reactive oxidation by-product formation — an effect reduced by subsequent sand filtration and eliminated by activated carbon. This highlights the critical value of bioassay data when evaluating oxidative treatment technologies.
“The umu test has been more widely used for determining mutagenicity of drinking water and effluent from wastewater treatment plants owing to its simplicity, convenience, and rapidity.”
— Peer-reviewed literature review on umu test applications in water quality assessment“Toxicity and genotoxicity bioassays should be an integral tool in the evaluation of complex wastewaters before their release to the environment.”
— Environmental toxicology research, SOS/umuC wastewater screening studyWhere the UMU-ChromoTest™ fits in your effluent management program
Routine genotoxicity screening of treated effluents before discharge to receiving water bodies, independent of chemical compliance monitoring.
Confirm that biological treatment, ozonation, UV, activated carbon, or advanced oxidation processes have actually reduced genotoxic burden — not just target chemical concentrations.
Screen for anomalous genotoxic loading events caused by process upsets, chemical spills, or unauthorized discharges to sewer systems.
Monitor genotoxic pharmaceutical residues — particularly fluoroquinolone antibiotics — in healthcare facility wastewater ahead of discharge to municipal systems.
Assess the genotoxic contribution of point-source effluent discharges to downstream rivers, lakes, and groundwater used for drinking water abstraction.
Generate ISO-compliant genotoxicity data for environmental impact assessments, permit applications, and peer-reviewed effluent characterization studies.
What chemical compliance monitoring cannot tell you
- Chemical analysis identifies what you are looking for. The UMU-ChromoTest™ detects genotoxic activity regardless of which compound is responsible — including unknowns, transformation products, and mixture effects.
- Effluents can pass all chemical compliance limits while still carrying significant aggregate genotoxic burden from hundreds of trace-level co-occurring compounds.
- Treatment processes that reduce chemical concentrations may paradoxically increase genotoxicity through reactive by-product formation — only detectable with a biological endpoint.
- The umuC assay is particularly sensitive to the classes of genotoxins most prevalent in industrial and hospital wastewater: nitroaromatics, fluoroquinolone antibiotics, PAHs, and chlorinated organic compounds.
- Results are available in under 8 hours — fast enough for same-day treatment adjustment decisions at operational WWTPs.
- ISO 13829 and DIN 38415 compliance supports use of data in regulatory submissions, environmental permits, and published research.
Internationally standardized for wastewater genotoxicity testing
The SOS/umuC assay has been formally standardized for water quality applications under ISO and DIN frameworks. The EBPI UMU-ChromoTest™ kit is designed to meet these requirements, with full documentation and EBPI standard operating procedures supplied with each kit.